11
Participants
Start Date
October 26, 2012
Primary Completion Date
July 28, 2016
Study Completion Date
July 13, 2017
Tocilizumab
Tocilizumab will be administered as indicated in the arm description.
Semmelweis University; 2nd Department of Paediatrics, Budapest
Hospital Gral de Niños Pedro Elizalde, Buenos Aires
UZ Leuven Gasthuisberg, Leuven
UZ Gent, Ghent
Children's Hospital Of Pittsburgh, Pittsburgh
Klinik Bremen-Mitte; Prof. Hess-Kinderklinik, Bremen
University of Louisville Research Foundation, Inc; Kosair Charities Pediatric Clinical Research Unit, Louisville
Hospital Universitario la Fe: Servicio de Reumatologia Pediatrica, Valencia
The University of Chicago;Department of Pediatrics, Chicago
Children's Speciality Center of Nevada, Las Vegas
Children's National Medical Center; Pediatric Rheumatology, Washington D.C.
The Floating Hospital for Children at Tufts Medical Center, Boston
Children's Hospital Boston Pediatric Medicine, Boston
Hackensack University Medical Center; Pediatric Rheumatology, Hackensack
Cincinnati Children'S Hospital Medical Center; Division of Rheumatology, Cincinnati
Alberta Children'S Hospital, Calgary
Hospital For Sick Children, Toronto
McGill University; Montreal Children's Hospital; Inflammatory, Autoimmune & Bone, Montreal
Uniwersytecki Szpital Kliniczny Nr 4 im. M. Konopnickiej; Oddz. Kardiolog. i Reumatolog. dla Dzieci, Lodz
Uniwersytecki Szpital Dzieciecy w Lublinie; Oddzial Pediatrii, Chorob Pluc i Reumatologii, Lublin
Hoffmann-La Roche
INDUSTRY